Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-005517

Chief Executive Officer sold 5,675 shares at $214.83 ($1,219,144)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-15 Exercise or conversion : show line 1 in the form +5,675 $57.76 $327,788 442,575 D
2023-02-15 Sale : show line 2 in the form −5,675 $214.83 $1,219,144 436,900 D
Open-market sales · 5,675 sh · avg $214.83 · $1,219,144

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-15 Exercise or conversion : show line 3 in the form ResMed Common Stock Options −5,675 54,540 D
Loading xslF345X03/form4.xml…